(1) Bristol-Myers Squibb Company, 5 Research Parkway, P.O. Box. 5100, 06492 Wallingford, CT, USA;(2) Present address: Medical Research Division, Lederle Laboratories, American Cyanamid Company, Pearl River, NY, USA
Abstract:
Summary Experimental evidence is presented to demonstrate that indolepyruvic acid is an intermediate in the rebeccamycin biosynthetic pathway. 3-14C]Indolepyruvic acid was prepared and efficiently incorporated (8%) into rebeccamycin bySaccharothrix aerocolonigenes.